Tfelt-Hansen Jacob, Ferreira Ana, Yano Shozo, Kanuparthi Deephti, Romero Jose R, Brown Edward M, Chattopadhyay Naibedya
Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine and Membrane Biology Program, Harvard Medical School, Boston, Massachusetts, USA.
Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1206-13. doi: 10.1152/ajpendo.00492.2004. Epub 2005 Jan 18.
Nitric oxide (NO) is a versatile second messenger. NO is produced by Leydig cells, where NO is a negative regulator of steroidogenesis. In cancer cells, NO is thought to have mutagenic and proliferative effects. We have previously shown that the calcium-sensing receptor (CaR) has promalignant effects in rat H-500 Leydig cancer cells, a model for humoral hypercalcemia of malignancy. Calcium, the major physiological ligand of the CaR, is a recognized intracellular cofactor in the process of NO production by virtue of its positive modulation of neuronal and endothelial nitric oxide synthase (NOS), but importantly, not of inducible (i) NOS activity. iNOS activity is regulated by changes in its expression level. Therefore, we investigated whether CaR activation changes iNOS expression. We found that high extracellular calcium (Cao2+) upregulates the level of mRNA for iNOS, whereas no change was seen in neuronal or endothelial NOS, as assessed by microarray and real-time PCR, respectively. The high Cao2+-induced iNOS upregulation was also detected by Northern and Western blotting. By quantitative real-time PCR, we showed that calcium maximally upregulates iNOS at 18 h. The effect of calcium was abolished by overexpression of a dominant-negative CaR (R185Q), confirming that the effect of Cao2+ was mediated by the CaR. Cells treated with high calcium had higher NO production than those treated with low calcium, as detected with the NO-specific DAF2-AM dye. This was confirmed in single-cell fluorescence determinations using confocal microscopy. In conclusion, high calcium upregulates the levels of iNOS mRNA and protein as well as NO production in H-500 cells, and the effect of Cao2+ on iNOS expression is mediated by the CaR.
一氧化氮(NO)是一种多功能的第二信使。睾丸间质细胞可产生NO,在该细胞中NO是类固醇生成的负调节因子。在癌细胞中,NO被认为具有致突变和增殖作用。我们之前已经表明,钙敏感受体(CaR)在大鼠H - 500睾丸间质癌细胞(一种恶性肿瘤体液性高钙血症模型)中具有促癌作用。钙是CaR的主要生理配体,因其对神经元型和内皮型一氧化氮合酶(NOS)具有正向调节作用,所以是NO生成过程中公认的细胞内辅助因子,但重要的是,对诱导型(i)NOS活性无此作用。iNOS活性受其表达水平变化的调节。因此,我们研究了CaR激活是否会改变iNOS的表达。我们发现,高细胞外钙(Cao2+)上调了iNOS的mRNA水平,而通过微阵列和实时PCR分别评估发现,神经元型或内皮型NOS无变化。通过Northern印迹和Western印迹也检测到了高Cao2+诱导的iNOS上调。通过定量实时PCR,我们表明钙在18小时时最大程度地上调iNOS。通过过表达显性负性CaR(R185Q)消除了钙的作用,证实了Cao2+的作用是由CaR介导的。用高钙处理的细胞比用低钙处理的细胞产生更多的NO,这是用NO特异性DAF2 - AM染料检测到的。使用共聚焦显微镜进行的单细胞荧光测定证实了这一点。总之,高钙上调了H - 500细胞中iNOS的mRNA和蛋白质水平以及NO的产生,并且Cao2+对iNOS表达的作用是由CaR介导的。